Near InfraRed Fluorescence Using Indocyanine Green and Magnetic Resonance Lymphography of Lymphatic Transport

PHASE1CompletedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

December 15, 2019

Primary Completion Date

March 15, 2020

Study Completion Date

March 15, 2020

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Indocyanine Green

A trained physician will inject 0.1 ml of Indocyanine Green into the web spaces of the hands in both upper extremities. Subjects may have up to five study visits to confirm feasibility, safety, and reproducibility.

DEVICE

MultiSpectral Imaging System

Once the Indocyanine Green is injected, the contrast is expected to fluoresce underneath the MultiSpectral Imaging System. Multispectral video and still images will be recorded at the study visits.

Trial Locations (1)

14642

University of Rochester, Rochester

All Listed Sponsors
lead

University of Rochester

OTHER

NCT04046146 - Near InfraRed Fluorescence Using Indocyanine Green and Magnetic Resonance Lymphography of Lymphatic Transport | Biotech Hunter | Biotech Hunter